Cargando…
Analysis of Circulating Tumor Cells in Patients with Non-Metastatic High-Risk Prostate Cancer before and after Radiotherapy Using Three Different Enumeration Assays
The characterization of circulating tumor cells (CTCs) can lead to a promising strategy for monitoring residual or relapsing prostate cancer (PCa) after local therapy. The aim of this study was to compare three innovative technologies for CTC enumeration in 131 high-risk patients with PCa, before an...
Autores principales: | Budna-Tukan, Joanna, Świerczewska, Monika, Mazel, Martine, Cieślikowski, Wojciech A., Ida, Agnieszka, Jankowiak, Agnieszka, Antczak, Andrzej, Nowicki, Michał, Pantel, Klaus, Azria, David, Zabel, Maciej, Alix-Panabières, Catherine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627099/ https://www.ncbi.nlm.nih.gov/pubmed/31185699 http://dx.doi.org/10.3390/cancers11060802 |
Ejemplares similares
-
Circulating Tumor Cells as a Marker of Disseminated Disease in Patients with Newly Diagnosed High-Risk Prostate Cancer
por: Cieślikowski, Wojciech A., et al.
Publicado: (2020) -
Baseline CTC Count as a Predictor of Long-Term Outcomes in High-Risk Prostate Cancer
por: Cieślikowski, Wojciech A., et al.
Publicado: (2023) -
Clinical Relevance of Circulating Tumor Cells in Prostate Cancer Management
por: Cieślikowski, Wojciech A., et al.
Publicado: (2021) -
Liquid Biopsy in Melanoma: Significance in Diagnostics, Prediction and Treatment Monitoring
por: Kamińska, Paula, et al.
Publicado: (2021) -
Liquid Biopsy Analysis as a Tool for TKI-Based Treatment in Non-Small Cell Lung Cancer
por: Buszka, Karolina, et al.
Publicado: (2022)